These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants. Weber B; Borkhardt A; Stoll-Becker S; Reiss I; Gortner L Turk J Pediatr; 2000; 42(3):181-5. PubMed ID: 11105614 [TBL] [Abstract][Full Text] [Related]
7. Bronchopulmonary dysplasia: then and now. Philip AG Neonatology; 2012; 102(1):1-8. PubMed ID: 22354063 [TBL] [Abstract][Full Text] [Related]
8. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Walsh MC; Yao Q; Gettner P; Hale E; Collins M; Hensman A; Everette R; Peters N; Miller N; Muran G; Auten K; Newman N; Rowan G; Grisby C; Arnell K; Miller L; Ball B; McDavid G; Pediatrics; 2004 Nov; 114(5):1305-11. PubMed ID: 15520112 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of bronchopulmonary dysplasia. Hayes D; Feola DJ; Murphy BS; Shook LA; Ballard HO Respiration; 2010; 79(5):425-36. PubMed ID: 19786727 [TBL] [Abstract][Full Text] [Related]
10. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia. Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G; Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865 [TBL] [Abstract][Full Text] [Related]
11. Ventilatory management and bronchopulmonary dysplasia in preterm infants. Gupta S; Sinha SK; Donn SM Semin Fetal Neonatal Med; 2009 Dec; 14(6):367-73. PubMed ID: 19766071 [TBL] [Abstract][Full Text] [Related]
12. Drug therapies in bronchopulmonary dysplasia: debunking the myths. Tin W; Wiswell TE Semin Fetal Neonatal Med; 2009 Dec; 14(6):383-90. PubMed ID: 19747890 [TBL] [Abstract][Full Text] [Related]
13. [From classic to new bronchopulmonary dysplasia]. Kramer BW; Lievense S; Been JV; Zimmermann LJ Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770 [TBL] [Abstract][Full Text] [Related]
14. Pathology of new bronchopulmonary dysplasia. Coalson JJ Semin Neonatol; 2003 Feb; 8(1):73-81. PubMed ID: 12667832 [TBL] [Abstract][Full Text] [Related]
16. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence? Thomas W; Speer CP Neonatology; 2008; 94(3):150-9. PubMed ID: 18679037 [TBL] [Abstract][Full Text] [Related]
17. Chronic lung disease of prematurity: a short history. Philip AG Semin Fetal Neonatal Med; 2009 Dec; 14(6):333-8. PubMed ID: 19699162 [TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
19. Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis. Carpenter TC; Stenmark KR Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S33-40. PubMed ID: 14730268 [TBL] [Abstract][Full Text] [Related]